insights_auto
Why is SYRE down 3,77%?
Dive Deeperchevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
97,63 US$
arrow_downward
-3,77%(-3,83) 1D
97,63 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 19 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
102,34 US$
High
103,50 US$
Low
97,47 US$
Mkt. cap
9,27 მლრდ.
Avg. vol.
1,10 მლნ.
Volume
628,95 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
Open
102,34 US$
High
103,50 US$
Low
97,47 US$
Mkt. cap
9,27 მლრდ.
Avg. vol.
1,10 მლნ.
Volume
628,95 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
News stories
From web sources and news partners
The Motley Fool
·
1 საათის წინ
The Semiconductor ETF Is on Track to Beat the S&P 500 for a 4th Straight Year. It Has Never Done That Before.
FXStreet
·
3 საათის წინ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
2 საათის წინ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
28 წუთის წინ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
About Spyre Therapeutics Inc
CEO-
Employees130
Founded1 იან. 2013
HeadquartersWaltham, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitespyre.com